Handong Jiang

发表

Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor‐dependent and independent pathways

B. Liu, Shan Xue, H. Cai, 2016, Respirology.

Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling.

J. Qu, Z. Fan, Zi-li Wang, 2013, Carcinogenesis.

The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC

Jianrong Xu, Jiejun Cheng, Huawei Wu, 2020, Scientific Reports.

The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis

Bi Chen, Jing Ai, Wenjie You, 2016, The Journal of Pharmacology and Experimental Therapeutics.

The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.

Shan Xue, H. Qin, Bi Chen, 2018, Cancer letters.

Structural colour using organized microfibrillation in glassy polymer films

Koichiro Tanaka, Masateru M. Ito, D. Yamaguchi, 2019, Nature.

Hypermethylation of the PTTG1IP promoter leads to low expression in early-stage non-small cell lung cancer

X. Ni, Qihan Wu, Xiaoming Tan, 2019, Oncology letters.

Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1.

Zili Wang, Han-dong Jiang, J. Qu, 2016, Oncology reports.

Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit

Zhan-jun Lu, Z. Jie, Qihui Huang, 2021, International Immunopharmacology.

Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer

Lifang Zhao, Shan Xue, Xue-qing Liu, 2022, Cell cycle.

Chronic microaspiration of bile acids induces lung fibrosis through multiple mechanisms in rats.

Shan Xue, H. Qin, Bi Chen, 2017, Clinical science.

Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China

Shan Xue, H. Ge, Q. Mao, 2021, Acta pharmacologica Sinica.

SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer

M. Geng, Xuchao Zhang, Zuoquan Xie, 2023, Signal transduction and targeted therapy.

TGR5 deficiency activates antitumor immunity in non-small cell lung cancer via restraining M2 macrophage polarization

Lifang Zhao, Shan Xue, Xue-qing Liu, 2021, Acta pharmaceutica Sinica. B.

Structural colour enhanced microfluidics

Sangamithirai Subramanian Parimalam, Masateru M. Ito, D. Yamaguchi, 2022, Nature Communications.

Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXRhighPD-L1low NSCLC to Anti–PD-1 Immunotherapy

Shan Xue, H. Qin, Bi Chen, 2019, Cancer Immunology Research.

Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1

Shan Xue, H. Qin, Bi Chen, 2017, Scientific Reports.

Overexpression of farnesoid X receptor in small airways contributes to epithelial to mesenchymal transition and COX-2 expression in chronic obstructive pulmonary disease.

Han-dong Jiang, Shan Xue, H. Qin, 2016, Journal of thoracic disease.

Interstitial lung abnormalities: What do we know and how do we manage?

K. Chung, B. Han, Feng Li, 2021, Expert review of respiratory medicine.

Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1

Han-dong Jiang, Shan Xue, H. Qin, 2017, Scientific Reports.

Nanodiamond mediated interfacial polymerization for high performance nanofiltration membrane

M. Shirakawa, R. Igarashi, Guoji Huang, 2020 .